Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
38.65
-0.81 (-2.05%)
At close: Nov 19, 2025, 4:00 PM EST
38.51
-0.14 (-0.36%)
After-hours: Nov 19, 2025, 7:17 PM EST
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $22.31 billion as of November 19, 2025. Its market cap has increased by 83.71% in one year.
Market Cap
22.31B
Enterprise Value
30.32B
1-Year Change
83.71%
Ranking
Category
Stock Price
$38.65
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $22.31B, an increase of 41.56%. That is a compound annual growth rate of 6.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 16.86B | 48.75% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |